|1.||Komine, Mayumi: 3 articles (12/2014 - 03/2003)|
|2.||Tamaki, Kunihiko: 3 articles (12/2014 - 03/2003)|
|3.||Vestergaard, Christian: 3 articles (12/2011 - 09/2004)|
|4.||Karakawa, Masaru: 2 articles (12/2014 - 12/2010)|
|5.||Ohtsuki, Mamitaro: 2 articles (12/2014 - 12/2010)|
|6.||Campanati, A: 2 articles (05/2012 - 12/2007)|
|7.||Offidani, A: 2 articles (05/2012 - 12/2007)|
|8.||Goteri, G: 2 articles (05/2012 - 12/2007)|
|9.||Stramazzotti, D: 2 articles (05/2012 - 12/2007)|
|10.||Ganzetti, G: 2 articles (05/2012 - 12/2007)|
02/01/2009 - "In the present study, chemokine CCL27, which be considered only selectively chemoattracts cutaneous lymphocyte antigen positive memory T cells and Langerhans cells, firstly demonstrated that it could induce the accumulation of NK cells into tumor by the intratumoral injection of CCL27-encoding fiber-mutant vector, AdRGD-CCL27. "
08/01/2003 - "Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector."
01/01/2010 - "Compared to controls, the short-term stress group showed greater cutaneous T-cell attracting chemokine (CTACK)/CCL27, RANTES, IL-12, and IFN-gamma gene expression at weeks 7, 20, and 32, higher skin infiltrating T cell numbers (weeks 7 and 20), lower tumor incidence (weeks 11-20) and fewer tumors (weeks 11-26). "
|2.||Scabies (Sarcoptic Mange)
07/01/2009 - "This study also showed that scabies molecules induced secretions of growth-related oncogene alpha (GROalpha), transforming growth factor alpha (TGFalpha), and cutaneous T-cell attracting chemokine (CTACK) from keratinocytes and IL-6 and granulocyte-colony stimulating factor (G-CSF) from fibroblasts. "
|3.||Atopic Dermatitis (Atopic Eczema)
03/01/2003 - "Increased serum cutaneous T cell-attracting chemokine (CCL27) levels in patients with atopic dermatitis and psoriasis vulgaris."
03/01/2006 - "Increased serum thymus and activation-regulated chemokine and cutaneous T cell-attracting chemokine levels in children with atopic dermatitis."
09/01/2004 - "Thymus- and activation-regulated chemokine (TARC)/CCL17 and cutaneous T cell-attracting chemokine (CTACK)/CCL27 are both pivotal mediators of the inflammatory reaction of atopic dermatitis (AD). "
05/01/2004 - "Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children."
02/01/2004 - "Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis."
12/01/2014 - "The cutaneous T cell-attracting chemokine (CTACK)/CCL27 is indispensable in skin inflammation. "
12/01/2010 - "Cutaneous T cell-attracting chemokine (CTACK)/CCL27 and macrophage inflammatory protein (MIP)-3α/CCL20 are the major inflammatory chemokines involved in skin inflammation. "
03/01/2006 - "Thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) are responsible for the trafficking of T helper type 2 lymphocytes into sites of allergic inflammation. "
05/01/2009 - "Human cytokine assay revealed that the amounts of human cutaneous T cell-attracting chemokine, leukemia inhibitory factor, and prolactin were substantially greater in the livers of the CCl4 (8W)+HUMSC (liver) group, with considerably reduced hepatic inflammation manifested by a micro positron emission tomography scan. "
|5.||Wounds and Injuries (Trauma)
01/01/2014 - "Differential response of human adipose tissue-derived mesenchymal stem cells, dermal fibroblasts, and keratinocytes to burn wound exudates: potential role of skin-specific chemokine CCL27."
01/01/2007 - "In this paper, it is hypothesized that in chronic wounds the process of homing of bone marrow-derived precursors of keratinocytes is disturbed, and that the interaction between cutaneous T-cell attracting chemokine (CTACK/CCL27) and soluble P-selectin glycoprotein ligand-1 (PSGL-1) can be the cause of this impairment. "
|1.||Interleukin-6 (Interleukin 6)
|3.||Transforming Growth Factor alpha (TGF-alpha)
|4.||Granulocyte Colony-Stimulating Factor (G-CSF)
|8.||Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
|9.||Biological Markers (Surrogate Marker)